BLOG

A Guide to Pre-Treatment Screenings for Stem Cell Therapy in Japan

8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Adipose-derived stem cell therapy is gaining attention globally as a field of regenerative medicine. For those considering this treatment in Japan, understanding the pre-treatment screening process is a crucial first step. Japanese medical institutions operate under strict safety regulations, and a thorough evaluation is essential to determine if the therapy is a suitable option for an individual’s health condition. This article explains the types of screenings and examinations typically required before undergoing adipose-derived stem cell therapy in Japan, helping you prepare for your consultation.

Why Pre-Treatment Screening is Essential for Stem Cell Therapy

Pre-treatment screening is not just a formality; it is a fundamental component of safety and personalized medicine. The primary goals of this comprehensive evaluation are to ensure patient safety, determine eligibility, and tailor the treatment plan to the individual’s specific needs. This process helps to identify any underlying health issues that might affect the treatment’s outcome or pose a risk to the patient.

In Japan, regenerative medicine is regulated by the Act on the Safety of Regenerative Medicine. This legal framework requires clinics to follow stringent protocols for cell processing and patient care. The screening process ensures that treatments are provided in compliance with these national standards, prioritizing patient well-being above all. A thorough medical check-up allows physicians to make an informed decision about whether the potential benefits of the therapy outweigh any potential risks for a given patient.

Key Components of the Medical Screening Process

The screening process for adipose-derived stem cell therapy involves several key steps. While the exact protocol may vary slightly between clinics and based on the patient’s condition, the core components generally include the following:

  1. Initial Consultation and Medical History Review: The process begins with a detailed consultation with a physician. You will be asked about your current health concerns, past medical history, any chronic conditions, previous surgeries, and current medications or supplements. Providing accurate and complete information is vital for a proper assessment.
  2. Comprehensive Blood Tests: Blood tests are a cornerstone of the screening process. They provide a wealth of information about your overall health. Standard tests often include a complete blood count (CBC), liver function tests, kidney function tests, and inflammatory markers. These help confirm that your body is in a suitable condition to undergo the procedure, from fat collection to cell infusion.
  3. Infectious Disease Screening: To ensure the safety of both the patient and the cell processing facility, screening for infectious diseases is mandatory. This typically includes tests for HIV, Hepatitis B (HBV), Hepatitis C (HCV), and syphilis. This step is critical for preventing contamination during the cell culturing process.
  4. Imaging Diagnostics (If Necessary): Depending on the therapeutic goal, imaging tests may be required. For example, if the therapy is being considered for joint issues like osteoarthritis, an MRI or X-ray of the affected joint might be necessary to assess the extent of the damage and establish a baseline for monitoring progress.
  5. Physical Examination: A thorough physical examination by the physician helps to assess your general health status and confirm the details discussed during the medical history review.

Understanding Eligibility for Adipose Stem Cell Therapy

Eligibility for adipose-derived stem cell therapy is determined on a case-by-case basis following a comprehensive medical evaluation. A physician must conclude that the treatment is appropriate for your specific health condition and goals. Generally, individuals who consult clinics are often concerned with conditions related to aging, chronic inflammation, or are seeking long-term health investments.

However, there are certain conditions where stem cell therapy may not be recommended. These can include active cancer, acute or severe systemic infections, certain blood disorders, or an allergy to the local anesthetic used during fat collection. It is important to understand that this is not an exhaustive list. The final decision regarding your eligibility can only be made by a qualified physician after a complete review of your health status and diagnostic test results. This treatment is not a cure for diseases and should not be considered a replacement for standard medical care.

How to Prepare for Your Consultation in Japan

For international patients or medical travelers, preparation is key to a smooth and productive consultation. Here are some tips to help you prepare:

  • Gather Your Medical Records: Collect all relevant medical records, including past diagnoses, test results, imaging reports, and a list of all current medications and supplements. Having these documents translated into English is highly recommended.
  • Prepare a List of Questions: Write down any questions or concerns you have about the treatment, the process, potential risks, and expected outcomes. This will help ensure you get all the information you need to make an informed decision.
  • Understand the Nature of the Treatment: Adipose-derived stem cell therapy in Japan is provided as a private, non-insured medical service. It’s important to inquire about the costs, treatment duration, and the number of sessions that may be suggested. Be sure to also discuss potential risks and side effects with your doctor.

Consultation at Grand Green Osaka Umekita Clinic

At Grand Green Osaka Umekita Clinic, we are dedicated to providing care based on a thorough understanding of each patient’s unique health situation. Our physicians conduct detailed consultations and necessary screenings to determine if adipose-derived stem cell therapy is a suitable option for you. We believe in empowering our patients with clear, accurate information so they can make confident decisions about their health.

Located conveniently in Osaka’s Umeda district, our clinic offers a professional and supportive environment for your consultation. We will review your medical information and discuss the treatment process, including the potential benefits, risks, and costs involved. The final treatment plan is always based on the physician’s comprehensive judgment. For more detailed information on our approach and the services we offer, please visit our regenerative medicine page. Learn more about our approach to Adipose-Derived Stem Cell Therapy.

Conclusion: Your First Step Towards Informed Care

The pre-treatment screening process is an indispensable first step for anyone considering adipose-derived stem cell therapy in Japan. It serves as a critical safety measure and ensures that any treatment plan is appropriately tailored to your individual health needs. By understanding what to expect from the screening and preparing for your appointment, you can engage in a more meaningful discussion with your physician. A comprehensive evaluation by a medical professional is the only way to determine your eligibility and embark on a treatment path grounded in safety and personalized care.

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact